Skip to main content
Premium Trial:

Request an Annual Quote

GeneNews, Oncore Pharma Ink Colorectal Cancer Test Deal

NEW YORK (360Dx) – GeneNews today said that it has signed a licensing and services deal with Oncore Pharma covering GeneNews' colorectal cancer test outside the US and Canada.

Oncore and its partners will commercialize the ColonSentry test in all countries outside the US and Canada under the five-year exclusive agreement. Initially, the deal will focus on the Netherlands, Belgium, Luxembourg, Germany, France, Switzerland, Austria, Spain, Monaco, Italy, Portugal, the United Kingdom, Ireland, Norway, Sweden, Finland, Denmark, Israel, and the United Arab Emirates.

The partners will also work together to commercialize ColonSentry in Canada.

GeneNews will receive a fixed fee per test, a special royalty payment equal to 10 percent of Oncore's yearly profits, and 1 million shares of Oncore's stock as part of the agreement. All ColonSentry tests will be processed in GeneNews' Richmond, Virginia laboratory.

The goal of the deal is to deploy 1.75 million ColonSentry tests during the next five years, Toronto-based GeneNews said.

Based in Cambridge, Massachusetts, Oncore develops and commercializes cancer products and services.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.